Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer-Reference-Cited by-同舟云学术

Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer

Published:2021-08-03 Issue:12 Volume:36 Page:2621-2627
ISSN:0179-1958
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Nakata Ken^ORCID,Komori Takamichi,Saso Kazuhiro,Ota Hirofumi,Kagawa Yoshinori,Morita Shunji,Noura Shingo,Hayashi Nobuyasu,Uemura Mamoru,Matsuda Chu,Satoh Taroh,Mizushima Tsunekazu,Murata Kohei,Doki Yuichiro,Eguchi Hidetoshi,

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s00384-021-04002-9.pdf

Reference19 articles.

1. Lacouture ME (2006) Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer. https://doi.org/10.1038/nrc1970

2. Agero ALC, Dusza SW, Benvenuto-Andrade C, Busam KJ, Myskowski P, Halpern AC (2006) Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2005.10.010

3. Lynch TJ, Kim ES, Eaby B, Garey J, West DP, Lacouture ME (2007) Epidermal growth factor receptor inhibitor–associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist. https://doi.org/10.1634/theoncologist.12-5-610

4. Chanprapaph K, Vachiramon V, Rattanakaemakorn P (2014) Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management. Dermatol Res Pract. https://doi.org/10.1155/2014/734249

5. Lacouture ME et al (2011) “Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities,” Support Care Cancer 19(8):1079–1095. https://doi.org/10.1007/s00520-011-1197-6

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factor Analysis for Anti-epidermal Growth Factor Receptor Monoclonal Antibody-induced Problematic Skin Toxicities in Patients With Liver Metastatic Colorectal Cancer;In Vivo;2024

2. Evaluation of the additional prophylactic effect of topical steroid ointment to systemic minocycline against anti-epidermal growth factor antibody-induced skin toxicities in metastatic colorectal cancer treatment;Supportive Care in Cancer;2023-12-06

3. Evaluation of the additional prophylactic effect of topical steroid ointment to systemic minocycline against anti-epidermal growth factor antibody-induced skin toxicities in metastatic colorectal cancer treatment;2023-08-11

4. Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody–induced skin toxicities in real-world metastatic colorectal cancer treatment;Supportive Care in Cancer;2023-08

5. Role of ErbB1 in the Underlying Mechanism of Lapatinib-Induced Diarrhoea: A Review;BioMed Research International;2022-06-28